Tag: Pharma
Lupin unveils strategic partnership program to expand reach of its long-acting...
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
AstraZeneca secures CDSCO approval for expanded use of Trastuzumab Deruxtecan in...
This marks the first and only antibody drug conjugate (ADC) in India with a tumour-agnostic indication, representing a significant advancement in precision oncology
Eli Lilly expands operations in India, to invest $1 Billion for...
Investment to expand manufacturing and global medicine supply capacity — resonating with the Make in India agenda
Dr Sharvil Patel named IPA President; Glenn Saldanha takes over as...
Dr Sharvil Patel, Managing Director, Zydus Lifesciences appointed as President, IPA. Glenn Saldanha, Chairman and Managing Director, Glenmark, appointed as Vice President, IPA
Starpharma and Genentech partner to advance next-generation cancer therapies
Starpharma’s DEP® platform technology offers significant benefits in drug development, including improved solubility, increased efficacy, pharmacokinetic control, and improved toxicity profiles
Indian pharma firms set for 7–9% revenue growth in FY26 despite...
ICRA maintains a stable outlook on the pharmaceuticals sector, supported by sustained demand in both domestic and export markets
AiMeD welcomes govt’s GST rate cut & MRP implementation relief for...
Recalling or re-labelling of existing stock already released in the market will not be mandatory
BioVoice eMagazine September 2025 | Issue 8 | Volume 6
The Cover Story focuses on the impact of massive tariffs levied by US admin under President, Donald Trump. This edition also features interview of Koji Wada, Managing Director, FUJIFILM India, along with the expert insights by Dr Ashish Gautam of Max Hospital and Vamsi Ravali Pattisapu of Tata Elxsi
2nd India MedTech Expo 2025 to showcase India’s prowess in MedTech...
Union ministers, industry leaders, global MedTech experts, and institutions of repute to join 3-day event
Top 20 global biopharma companies report 5.7% fall in market capitalization...
Tariffs, pricing pressures erode $200 billion in value for top biopharma firms; Alnylam and Novartis buck the trend with strong gains